CDEK
← All organizations

89bio Ltd.

For profitWebsite ↗

Also known as: 89bio, Inc. | 89bio Ltd.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 29, 2019

Last known activity

May 24, 2024

Acquired by Roche on Oct 1, 2025

Timeline

2010s

  1. Jan 31, 2018

    89bio Ltd.— Founded

2020s

  1. Oct 1, 2025

    Roche— Acquired By

Drugs by trial phase (1 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

Details

Founded
San Francisco, CA, US Jan 31, 2018
Last known activity
May 24, 2024